Navigation Links
Essilor's First-Half 2008 Results
Date:8/27/2008

for a total investment of EUR75.7 million.

- In Europe, Essilor acquired all outstanding shares in Italy's Galileo

(EUR13 million in revenue) and Bulgaria's Optymal (EUR1 million), and

also acquired a majority stake in Netherlands-based O'Max (EUR3

million).

- In the United States, Essilor of America added six

laboratories to its network: Interstate ($26 million in revenue),

Empire ($23 million) Advance ($6 million), Future TN, ($3 million),

Deschutes ($3 million) and Rainbow in Puerto Rico ($3 million).

Nikon-Essilor also acquired a minority holding in Encore Optics.

- In Canada, Essilor acquired a majority interest in Westlab

(C$4 million in revenue).

- In Asia, Essilor acquired Malaysia's Frame N Lenses (EUR2

million in revenue) and India's Rx 20/20 (EUR1 million).

In June, Essilor also announced the acquisition of Satisloh, the world's leading supplier of prescription laboratory equipment, with EUR161 million in 2007 revenue. The agreement is subject to certain conditions precedent.

Gross margin up 1.4% to EUR867 million

Gross margin (revenue less cost of goods sold, expressed as a percentage of revenue) stood at 57.0%, compared with 57.9% in first-half 2007. The decline was mainly due to the dilutive impact of acquisitions-particularly OOGP (contact lens distribution), KBco (polarized lens distribution) and ILT (ophthalmic lens distribution), all of which were acquired in 2007-whose margins are structurally lower than the rest of the Company.

Operating expenses up 0.5% to EUR590.7 million

Operating expenses were virtually stable in the first half and accounted for 38.9% of consolidated revenue, versus 39.8% in the prior-year period, when they amounted to EUR587.5 million.
Operating expenses comprised:

- R&D and engineering costs of EUR71.3 million (net of a

EUR5.4 million tax credit), representi
'/>"/>

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Biopure Announces 2008 Third Quarter Financial Results
2. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
3. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
4. Arpida Reports Interim Results for Six Months to 30 June 2008
5. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
6. Rosetta Genomics Reports Second Quarter 2008 Financial Results
7. VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
8. Arno Therapeutics Announces Second Quarter 2008 Financial Results
9. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
10. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
11. Yongye Biotechnology International Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 29, 2015 Elsevier , ... products and services, today announced the highlights of its ... 2014 Journal Citation Reports® (JCR) published by Thomson Reuters, ... from 2013 to 2014, ahead of the aggregate across ... rank in 62 subject categories, up from 61 in ...
(Date:6/26/2015)... June 26, 2015  A San Francisco company, Pembient, ... with synthetic rhino horn: beer in China ... . In response to the emerging industry, two ... and sale of synthetic rhino horn.  ... Save the Rhino International (SRI) released a ...
(Date:6/26/2015)... The report "Biolubricants Market by ... fluids, Chainsaw oils, Mold Release Agents), End Use (Industrial, ... trends and Forecasts to 2020" published by MarketsandMarkets, The ... 2020 at a CAGR of 6.27% between 2015 and ... and   66 Figures spread through 170 Pages and ...
(Date:6/25/2015)... ... 25, 2015 , ... The American Brain Tumor Association announced ... Family Conference, Providing and Pursuing Answers: Advances in Research, Treatment and Care. The ... July 24-25, 2015. , “As advances in research accelerate the arrival of precision ...
Breaking Biology Technology:Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3Rhino Experts Oppose Synthetic Rhino Horn as Solution to Poaching Crisis 2Biolubricants Market Worth $2,972.13 Million by 2020 2Biolubricants Market Worth $2,972.13 Million by 2020 3Nationally Recognized Brain Tumor Experts to Speak at American Brain Tumor Association Patient and Family Conference 2
... Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) today announced ... phase 3 study at the 47th Annual Meeting of ... PA. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO ) , ... Infectious Diseases, Chair of the Infection Prevention and Control ...
... ThermoGenesis Corp. (Nasdaq: KOOL ), a leading ... cells, announced today it will report financial results for the ... 5, 2009. , Company,s Conference Call and ... Thursday, November 5, 2009 at 2:00 PM Pacific (5:00 PM ...
... LAKE, N.J., Oct. 30 Eisai Inc. today announced ... with eribulin mesylate (E7389), discovered and developed by the ... cancer. , This global Phase III study, known as ... Versus E7389), was an open-label, randomized, parallel two-arm, multi-center ...
Cached Biology Technology:Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting 2Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting 3Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting 4Thermogenesis Corp. to Announce First Quarter Fiscal 2010 Results on November 5, 2009 2Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival 2Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival 3Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival 4
(Date:6/17/2015)... 17, 2015  Crossmatch™, a leading provider of ... U.are.U ® 4500 fingerprint readers have been ... Inc., a San Jose, CA ... security, improve accountability and reduce fraud at the ... identity confirmation for employee sign in and transaction ...
(Date:6/16/2015)... YORK , June 16, 2015  With the ... world, security remains a top concern. The recent compromise ... confirms the need for strong authentication within government agencies. ... Token, a biometric one-time password (OTP) authenticator, has been ... Standards (FIPS) 140-2 Level 3 validation for tamper proofing. ...
(Date:6/16/2015)... 16, 2015 Fingerprint Cards (FPC) raises ... it will amount to at least 340 MSEK to that ... rapid increase in market growth and orders received the revenue ... that revenue for 2015 will exceed 1,500 MSEK to an ... 2,200 MSEK. Due to receipt of orders of ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3
... to the future of the oceans, suggests a new report ... 8th issue of Current Biology, a publication of Cell Press. ... first evidence that the health of the deep sea, as ... with the diversity of species living there. For the ...
... in the numbers of copies of genes, occur when ... stalls and then switches to a different genetic template, ... in a report that appears today in the journal ... Stalling and Template Switching, said Dr. James R. Lupski, ...
... research published online this week in the open-access journal ... the fruit fly, and comes to a surprising new ... on the presence of the Y chromosome, which is ... But other animal groups have evolved different systems. James ...
Cached Biology News:Deep-sea species' loss could lead to oceans' collapse, study suggests 2Copy number variation may stem from replication misstep 2Copy number variation may stem from replication misstep 3
Mol wt: monoisotopic mol wt1,045.5423 Da by calculation...
Bis-Acrylamide (bis) is a monomer used as a crosslinker with acrylamide to form polyacrylamide electrophoretic gels. This 2% bis solution is supplied as 500 ml....
Anti-human VEGFR-2/KDR (Protein-A Purified) Polyclonal Antibody...
Mouse monoclonal antibody to Lats2....
Biology Products: